Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 821

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 821
---
 a forum for the exchange of information with respect to the Development of Licensed ADCs and Licensed Products in the
Territory.

3.2 Role. The JSC shall:

(a) Provide a forum for each Party to keep the other Party reasonably informed with respect to material Exploitation activities conducted
by or under the authority of such Party or its Affiliates with respect to the Licensed ADCs and Licensed Products; and

(b) Perform
such other duties as are specifically assigned to the JSC in this Agreement.

3.3 Committee Membership. The JSC shall
be composed of [***]representatives from each of Aadi and WuXi Biologics, selected by such Party. Unless the Parties otherwise agree, Aadi and WuXi Biologics shall each be entitled to appoint [***] representatives to the JSC. Either Party may
replace its respective JSC representatives at any time with prior written notice to the other Party. Each representative to the JSC shall be an employee of the applicable Party, unless otherwise agreed by both Parties. Both Parties acknowledge and
agree

G-12

that DAC may appoint [***] representatives to attend any JSC meeting provided that such representatives and DAC are subject to confidentiality and non-use
obligations no less stringent than the terms of Article IX.

3.4 Committee Meetings. The JSC shall meet [***], or as
more or less often as otherwise agreed to by the Parties. All JSC meetings may be conducted by telephone, video-conference, in person, or in writing as determined by the JSC. Each Party shall bear its own personnel and travel costs and expenses
relating to JSC meetings. With the prior written consent of the other Party [***], other employee representatives of a Party may attend any JSC meeting as non-voting observers.

3.5 No Decision-Making Authority. The JSC shall serve solely as a forum for exchange of information between the Parties
[***].

3.6 Alliance Managers. Within [***] following the Effective Date, each Party shall appoint a representative
(“Alliance Manager”) to facilitate communications between the Parties (including, coordinating the transfer of Data and other Licensed Know-How as required under this Agreement) and to act as
a liaison between the Parties with respect to such other matters as the Parties may mutually agree in order to maximize effective and efficient exchange of information as required under this Agreement. Each Party may replace its Alliance Manager
with an alternative representative at any time with prior written notice